Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Assumes Aetna (AET) at Overweight
-
Cantor Fitzgerald Starts Centene (CNC) at Overweight
-
Cantor Fitzgerald Assumes UnitedHealth Group (UNH) at Overweight
-
Cantor Fitzgerald Assumes Anthem (ANTM) at Neutral
-
Cantor Fitzgerald Assumes Humana (HUM) at Neutral
-
Cantor Fitzgerald Reiterates Neutral on Web.com Group (WEB) Ahead of 4Q Release
-
Cantor Fitzgerald Reiterates OW Rating and $46 PT on Yelp (YELP) Ahead of 4Q Report
-
Cantor Fitzgerald Reiterates OW Rating and $8 PT on Pacific Biosciences (PACB) Following Solid Results
-
Cantor Fitzgerald Reiterates OW Rating and $175 PT on Expedia (EXPE) Into Results
-
Cantor Fitzgerald Remains Sidelined on Twitter (TWTR) Ahead of 4Q Report
-
Cantor Fitzgerald Reiterates Overweight on Athenahealth (ATHN) Following 4Q Report
-
Gartner (IT) PT Raised to $114 at Cantor Fitzgerald Following 4Q
-
Amazon.com (AMZN) PT Lowered to $965 at Cantor Fitzgerald
-
Corium Internation (CORI) Prices 6.67M Shares at $3
-
Corium Prices Follow-On Offering of Common Stock
-
Shutterfly Inc. (SFLY) PT Lowered to $50 at Cantor Fitzgerald
-
Facebook (FB) PT Raised to $175 at Cantor Fitzgerald
-
American Capital Agency (AGNC) Enters $750M ATM Common Stock Offering Program
-
American Capital Agency (AGNC) Tops Q4 EPS by 5c
-
AGNC Investment Corp. Announces At The Market Offering Program of Common Stock
-
Corium Internation (CORI) Plans Offering of Common Stock
-
Corium Announces Proposed Public Offering of Common Stock
-
Illumina (ILMN): Results Ahead Of Preannouncement - Cantor
-
Synergy Pharma (SGYP) Prices 20.3M Shares at $6.15
-
Abpro Expands Senior Leadership Team and Announces Adam Mostafa as Chief Financial Officer
-
Synergy Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Acxiom (ACXM) PT Raised to $33 at Cantor Fitzgerald Following 3Q Report
-
After-Hours Stock Movers 01/31: (OSTK) (XOMA) (AAPL) Higher; (CATB) (SGYP) (BOOT) Lower (more...)
-
Synergy Pharma (SGYP) to Offer $125M in Common Stock
-
Synergy Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Downgrades Dimension Therapeutics (DMTX) to Neutral
-
Cantor Fitzgerald Reiterates Outperform on Athenahealth (ATHN) Ahead of 4Q Report
-
Amazon (AMZN) Poised to Report Strong Q4 Amid Robust Holiday Season - Cantor Fitzgerald
-
Facebook Q4 Should Reflect Healthy Sustained Demand For Social Ad Spending, Mobile Growth - Cantor
-
Ex-Jefferies bond trader Litvak guilty on one of 10 fraud counts
-
Cantor Fitzgerald Reiterates Overweight on PayPal (PYPL) Following Strong 4Q
-
Equity LifeStyle Properties (ELS) PT Raised to $73.50 at Cantor Fitzgerald Following 4Q
-
NantHealth (NH) PT Lowered to $15 at Cantor Fitzgerald; Reiterates Overweight
-
Strong Alphabet (GOOG) (GOOGL) Print Driven by Mobile/YouTube/Programmatic - Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Vantiv (VNTV) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Global Payments (GPN) at Overweight
-
UPDATE: Cantor Fitzgerald Starts First Data Corporation (FDC) at Neutral
-
Cantor Fitzgerald Downgrades Acadia Healthcare (ACHC) to Neutral
-
Northern Dynasty Announces Closing of US$37.444 Million Bought Deal Offering
-
eBay (EBAY) PT Raised to $31 at Cantor Fitzgerald
-
Ex-Jefferies trader's jury edges toward verdict, stalls on two counts
-
FinTech Acquisition Corp. II Announces Completion of $175,000,000 Initial Public Offering
-
Alibaba (BABA) PT Raised to $120 at Cantor Fitzgerald
-
Rambler Releases Fiscal 2017 Production Guidance and Stub Period Production Results
-
Ocular Therapeutix (OCUL) Prices 3.57M Common Stock Offering at $7/Share

